MYXOID ROUND CELL LIPOSARCOMA
Clinical trials for MYXOID ROUND CELL LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID ROUND CELL LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID ROUND CELL LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take aim at multiple cancer types in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for people with certain advanced cancers (bladder, melanoma, head/neck, ovarian, lung, esophageal, stomach, sarcoma) that carry a protein called MAGE-A4. Patients' own immune cells are genetically modified to recognize and …
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
New cell therapy takes on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new treatment called BOXR1030, which uses specially designed immune cells to target a protein (GPC3) found on certain advanced solid tumors. The study involves 7 adults with liver, lung, skin, or soft tissue cancers that have not responded to standa…
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Sotio Biotech Inc. • Aim: Disease control
Last updated May 17, 2026 04:11 UTC